Translational pharmacokinetic-pharmacodynamic analysis in the pharmaceutical industry: an IQ Consortium PK-PD Discussion Group perspective-Reference-Cited by-同舟云学术

Translational pharmacokinetic-pharmacodynamic analysis in the pharmaceutical industry: an IQ Consortium PK-PD Discussion Group perspective

Published:2017-10 Issue:10 Volume:22 Page:1447-1459
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Wong Harvey,Bohnert Tonika,Damian-Iordache Valeriu,Gibson Christopher,Hsu Cheng-Pang,Krishnatry Anu Shilpa,Liederer Bianca M.,Lin Jing,Lu Qiang,Mettetal Jerome T.,Mudra Daniel R.,Nijsen Marjoleen J.M.A.,Schroeder Patricia,Schuck Edgar,Suryawanshi Satyendra,Trapa Patrick,Tsai Alice,Wang Haiqing,Wu Fan

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference80 articles.

1. Trial watch: Phase II failures: 2008–2010;Arrowsmith;Nat. Rev. Drug Discov.,2011

2. Trial watch: phase III and submission failures: 2007–2010;Arrowsmith;Nat. Rev. Drug Discov.,2011

3. Preclinical pharmacokinetic/pharmacodynamic modeling and simulation in pharmaceutical industry: an IQ consortium survey examining the current landscape;Schuck;AAPS J.,2015

4. Optimization of human dose prediction by using quantitative and translational pharmacology in drug discovery;Bueters;Future Med. Chem.,2015

5. Translational pharmacokinetic/pharmacodynamic analysis in cancer pharmacology: a tool to maximize the value of antitumor efficacy from tumor bearing mice;Wong;Drug Discov. Today Technol.,2016

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic Models of Tafenoquine: Insights for Optimal Malaria Treatment Strategies;Pharmaceutics;2024-08-26

2. Physiologically‐based pharmacokinetic/pharmacodynamic modeling to predict tumor growth inhibition and the efficacious dose of selective estrogen receptor degraders in humans;Biopharmaceutics & Drug Disposition;2023-04-27

3. Integrated pharmacokinetic/pharmacodynamic/efficacy analysis in oncology: importance of pharmacodynamic/efficacy relationships;Overcoming Obstacles in Drug Discovery and Development;2023

4. Design and Measurement of Drug Tissue Concentration Asymmetry and Tissue Exposure-Effect (Tissue PK-PD) Evaluation;J MED CHEM;2022

5. Design and Measurement of Drug Tissue Concentration Asymmetry and Tissue Exposure-Effect (Tissue PK-PD) Evaluation;Journal of Medicinal Chemistry;2022-07-05